A High Intensity Electronic Health Intervention for the Reduction of Learning Disparities in Childhood Cancer Survivors

Launched by CITY OF HOPE MEDICAL CENTER · Jun 20, 2022

Keywords

ClinConnect Summary

This clinical trial is looking at a special online program designed to help children who have survived cancer, specifically those treated for acute leukemia or lymphoblastic lymphoma. While many of these children can be cured, some may face challenges with learning and school after their treatment. The goal of the study is to see if providing parents with helpful information and tips through video calls and a dedicated website can improve their child's learning and school performance compared to usual support services.

To participate in this study, children need to be between 6 and 12 years old, have completed their cancer treatments, and be in remission. Their parent or caregiver should speak English or Spanish and be involved in their daily lives. Participants will have the chance to engage in educational sessions and resources specifically designed to support their learning needs. It’s important to note that the study is currently recruiting, and children with certain conditions or those who have recently taken part in similar studies may not be eligible.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Documented informed consent of the participant and/or legally authorized representative
• • Assent, when appropriate, will be obtained per institutional guidelines
• • Primary participating parent/caregiver is English- or Spanish-speaking (any race/ethnicity)
• • Child is aged 6-12 years (yr.) (for the website usability pre-study, child is age 8 - 12 yrs.)
• • Child understands English (but can be bilingual)
• • Child treated for acute leukemia (e.g., acute lymphoblastic leukemia, acute myelogenous leukemia) or lymphoblastic lymphoma
• • Child is in cancer remission and has completed cancer therapies, including maintenance treatment
• • Primary participating parent/caregiver has daily contact with the child
• • Child is enrolled in school
• Exclusion Criteria:
• • Recent or current participation in a behavioral intervention study with a similar focus
• • History of major psychiatric condition (e.g., psychosis) in parent or child
• • Severe neurodevelopmental disorder in the child (e.g., down syndrome, intellectual disability)
• • Child has previously used the IXL online learning program extensively and unwilling to regularly use it again
• • Any other condition that would, in the investigator's judgment, contraindicate the patient's participation in the clinical study due to safety concerns with clinical study procedures
• • Prospective participants who, in the opinion of the investigator, may not be able to comply with all study procedures (including compliance issues related to feasibility/logistics)